SB-258719
id:
sb-258719-252-17981933
title:
SB-258719
text:
SB-258719 is a drug developed by GlaxoSmithKline which acts as a selective 5-HT7 receptor partial inverse agonist, and was the first such ligand identified for 5-HT7. Its use in research has mainly been in demonstrating the potential use for 5-HT7 agonists as potential novel analgesics, due to the ability of SB-258719 to block the analgesic effects of a variety of 5-HT7 agonists across several different testing models.
brand slug:
wiki
category slug:
encyclopedia
description:
Drug
original url:
https://en.wikipedia.org/wiki/SB-258719
date created:
date modified:
2024-01-22T21:29:37Z
main entity:
{"identifier":"Q855345","url":"https://www.wikidata.org/entity/Q855345"}
image:
{"content_url":"https://upload.wikimedia.org/wikipedia/commons/6/68/SB-258719_structure.png","width":598,"height":216}
fields total:
13
integrity:
15